Laixing Wang

1.4k total citations
34 papers, 506 citations indexed

About

Laixing Wang is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Laixing Wang has authored 34 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 11 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Laixing Wang's work include Neurological disorders and treatments (8 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and MicroRNA in disease regulation (7 papers). Laixing Wang is often cited by papers focused on Neurological disorders and treatments (8 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and MicroRNA in disease regulation (7 papers). Laixing Wang collaborates with scholars based in China, Ireland and Taiwan. Laixing Wang's co-authors include Yiqun Cao, Xiao‐Ping Zhou, Guosheng Han, Jianmin Liu, Xiaowu Hu, Zhijian Yue, Yanan Li, Bin Hao, Dongwei Dai and Jianmin Liu and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Medicine.

In The Last Decade

Laixing Wang

32 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laixing Wang China	14	177	167	125	80	65	34	506
Ran Xu Germany	13	241 1.4×	95 0.6×	132 1.1×	27 0.3×	27 0.4×	34	593
Haiyu Luo China	9	221 1.2×	103 0.6×	36 0.3×	34 0.4×	105 1.6×	11	578
Linda M. van der Graaf Netherlands	15	229 1.3×	94 0.6×	34 0.3×	39 0.5×	68 1.0×	23	572
Lijing Kang China	10	333 1.9×	80 0.5×	44 0.4×	31 0.4×	110 1.7×	14	740
Mei-Juan Shi China	6	273 1.5×	72 0.4×	34 0.3×	30 0.4×	86 1.3×	6	611
Dao Ly Canada	7	396 2.2×	84 0.5×	74 0.6×	53 0.7×	54 0.8×	11	649
Shuping Qu China	9	117 0.7×	53 0.3×	95 0.8×	32 0.4×	131 2.0×	18	468
Seiji Hosokawa Japan	14	146 0.8×	72 0.4×	34 0.3×	22 0.3×	45 0.7×	68	550
Nabeela Nathoo Canada	9	109 0.6×	70 0.4×	30 0.2×	28 0.3×	21 0.3×	36	503
Antoine Fournier France	10	114 0.6×	54 0.3×	26 0.2×	50 0.6×	53 0.8×	20	354

Countries citing papers authored by Laixing Wang

Since Specialization

Citations

This map shows the geographic impact of Laixing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laixing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laixing Wang more than expected).

Fields of papers citing papers by Laixing Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laixing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laixing Wang. The network helps show where Laixing Wang may publish in the future.

Co-authorship network of co-authors of Laixing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Laixing Wang. A scholar is included among the top collaborators of Laixing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laixing Wang. Laixing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jin, Hui, Yiping Han, Laixing Wang, et al.. (2021). Incorporation of green emission polymer dots into pyropheophorbide-α enhance the PDT effect and biocompatibility. Photodiagnosis and Photodynamic Therapy. 37. 102562–102562. 6 indexed citations

He, Miaoxia, Weiwei Zhang, Lei Gao, et al.. (2021). Aggregative Perivascular Tumor Cell Growth Pattern of Primary Central Nervous System Lymphomas Is Associated with Hypoxia-Related Endoplasmic Reticulum Stress. Journal of Cancer. 12(13). 3841–3852. 2 indexed citations

Zhang, Pei, Maomao Wang, Yang Wang, et al.. (2020). Risk factors associated with the progression of COVID-19 in elderly diabetes patients. Diabetes Research and Clinical Practice. 171. 108550–108550. 16 indexed citations

Zhu, Wei, Ying-Hua Gao, Zhibin Lu, et al.. (2017). Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy. Photochemical & Photobiological Sciences. 16(11). 1623–1630. 16 indexed citations

Zhu, Wei, Laixing Wang, Ying-Hua Gao, et al.. (2017). Synthesis and biological evaluation of 173-dicarboxylethyl-pyropheophorbide-a amide derivatives for photodynamic therapy. Bioorganic & Medicinal Chemistry Letters. 28(16). 2784–2788. 6 indexed citations

Li, Yanan, Mengmeng Li, Laixing Wang, et al.. (2017). Integrated in silico-in vitro characterization, identification and disruption of the intermolecular interaction between SH3 domain-containing protein kinases and human pituitary tumor-transforming gene 1. General Physiology and Biophysics. 36(1). 91–98. 4 indexed citations

Wang, Laixing, Jianwei Li, Jianhong Li, et al.. (2015). Antitumor activity of photodynamic therapy with a chlorin derivative in vitro and in vivo. Tumor Biology. 36(9). 6839–6847. 15 indexed citations

Chen, Xin, Bin Hao, Ying Liu, et al.. (2014). The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma. Biochemical and Biophysical Research Communications. 446(1). 364–369. 34 indexed citations

Dai, Dongwei, Yanan Li, Qiong Lu, et al.. (2014). GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment. Cellular Physiology and Biochemistry. 33(4). 1026–1035. 6 indexed citations

10.

Han, Guosheng, Laixing Wang, Wenyuan Zhao, et al.. (2013). High expression of leptin receptor leads to temozolomide resistance with exhibiting stem/progenitor cell features in gliobalastoma. Cell Cycle. 12(24). 3833–3840. 20 indexed citations

11.

Lu, Qiong, Dongwei Dai, Wenyuan Zhao, et al.. (2013). Association between MTHFR 677C>T polymorphism and risk of gliomas: evidence from a meta-analysis. Tumor Biology. 34(5). 2801–2807. 5 indexed citations

12.

Cao, Yiqun, et al.. (2011). γ-secretase inhibitor up-regulates vascular endothelial growth factor receptor-2 and endothelial nitric oxide synthase. Experimental and Therapeutic Medicine. 2(4). 725–729. 1 indexed citations

13.

Hu, Xiaowu, Xiao‐Ping Zhou, Laixing Wang, et al.. (2010). Avoidance and Management of Surgical and Hardware-Related Complications of Deep Brain Stimulation. Stereotactic and Functional Neurosurgery. 88(5). 296–303. 53 indexed citations

14.

Han, Guosheng, Yingying Jing, Yuhui Zhang, et al.. (2010). Osteogenic differentiation of bone marrow mesenchymal stem cells by adenovirus-mediated expression of leptin. Regulatory Peptides. 163(1-3). 107–112. 16 indexed citations

15.

Hu, Xiaowu, et al.. (2009). Risks of intracranial hemorrhage in deep brain stimulation and ablation in patients With movement disorders. Zhonghua shenjing waike zazhi. 25(4). 321–323. 1 indexed citations

16.

Hu, Xiaowu, et al.. (2009). Risks of intracranial hemorrhage in patients with Parkinson's disease receiving deep brain stimulation and ablation. Parkinsonism & Related Disorders. 16(2). 96–100. 83 indexed citations

17.

Wang, Laixing. (2004). The comparison of stimulation with ablation procedure in bilateral surgical treatment of Parkinson's disease. Zhonghua shenjing waike zazhi. 1 indexed citations

18.

Wang, Laixing. (2004). Clinical application of subthalamic nucleus stimulation for Parkinson disease.

19.

Wang, Laixing. (2004). The method for subthalamic nucleus targeting in deep brain stimulation. 1 indexed citations

20.

Wang, Laixing. (2002). The different ablative procedures for Parkinson's disease and their effects. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact